Emergent BioSolutions to Participate in Investor Conferences

On March 1, 2021 Emergent BioSolutions Inc. (NYSE: EBS) repoted that members of the company’s senior management team will participate in the following investor conferences (Press release, Emergent BioSolutions, MAR 1, 2021, View Source [SID1234575891]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Inaugural Global Plasma Summit
March 11, 2021
Company fireside chat scheduled at 12:50 pm EST

KeyBanc Life Sciences & MedTech Investor Forum
March 24, 2021
Company fireside chat scheduled at 1:15 pm EST
Chardan 4th Annual Manufacturing Summit
April 26-27, 2021
Fireside chat date and time will be updated on the Emergent website as the information becomes available.
Truist 7th Annual Life Sciences Summit
May 4-5, 2021
Presentation date and time will be updated on the Emergent website as the information becomes available.
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.